phase-iii
DCGI allows Bharat Biotech to conduct phase-III trials for COVID’s intranasal booster dose-
admin
By PTI NEW DELHI/ HYDERABAD: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for ...
By PTI NEW DELHI/ HYDERABAD: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for ...
Information
Latest Updates
Health
Top Categories
Awam Ka Sach